Dr. Hallett is executive vice president of chemistry at Evotec, where he has global responsibility for all of Evotec’s chemistry activities and capabilities. He is a medicinal chemist by training, with 15 years drug discovery experience in the pharma and biotech sectors with a particular focus on diseases of the central nervous system, pain and inflammation. He was educated at Cambridge before obtaining a PhD at the University of Manchester followed by post-doctoral studies at the University of Texas at Austin. He joined Evotec in 2005 after almost 10 years at Merck’s neuroscience research facility in the UK. He is a member of the American Chemical Society, the Society for Neuroscience and the Society of Chemical Industry.